Singapore: Australis Scientific has been named the 2025 MedTech Innovator (MTI) Asia Pacific (APAC) Grand Prize winner, receiving US$175,000 in non-dilutive funding for its smart patch that delivers minimally invasive neuromodulation therapy for overactive bladder. (US$1=RM4.19)
According to BERNAMA News Agency, the announcement was made at the MTI Asia Pacific Grand Finals in Singapore, marking the first time the event has been hosted independently in the region. This highlights MTI’s expanding influence as APAC’s leading medtech accelerator.
MTI founder and chief executive officer (CEO), Paul Grand, stated that Australis Scientific’s innovation has the potential to improve millions of lives. He noted that the innovation reflects the momentum and breakthrough solutions emerging across APAC, which are less invasive, more accessible, and designed for global adoption.
Australis Scientific co-founder and CEO, Nicky Agahari, emphasized that the recognition underscores the value of collaboration within the MTI ecosystem, comprising founders, mentors, and strategic partners.
The other finalists-F.MED, HemoTag, and OsseoLabs-each received US$10,000 as runner-up prizes. Additional awards were presented, including the Cambridge Consultants Product Development Award (US$25,000) to F.MED, the EnterpriseSG STARTUP SG Grant (S$50,000) to HiCura Medical, the Best Video Competition Award (US$5,000) to Borns Medical Robotics, and OsseoLabs was granted a one-year membership to Johnson and Johnson’s global incubator network at JLABS Singapore.
The winner was selected through a live audience vote following presentations and a Q and A session with a panel of medtech executives, including representatives from Johnson and Johnson MedTech, B. Braun Medical, and Becton Dickinson.
The 2025 APAC Accelerator featured 20 startups selected from over 550 applications across the region. Over four months, participants received tailored mentorship, investor exposure, and access to MTI’s global network of healthcare leaders.
MTI’s 2025 APAC programme sponsors include Johnson and Johnson MedTech, B. Braun Medical, Becton Dickinson, Siemens Healthineers, Teleflex, Cambridge Consultants, The Mullings Group, Enterprise Singapore, and Blue Goat Cyber.
Applications are now open for the 2026 MTI Asia Pacific Accelerator Programme, which will expand to South Korea through the MedTech Spotlight Pitch Event Road Tour in collaboration with the Korea Health Industry Development Institute (KHIDI).